Mirae Asset Global Investments’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7K | Buy |
2,277
+326
| +17% | +$1.54K | ﹤0.01% | 1481 |
|
|
2025
Q1 | $9.15K | Buy |
1,951
+8
| +0.4% | +$38 | ﹤0.01% | 1477 |
|
|
2024
Q4 | $9.35K | Sell |
1,943
-165
| -8% | -$794 | ﹤0.01% | 1520 |
|
|
2024
Q3 | $9.84K | Buy |
2,108
+370
| +21% | +$1.73K | ﹤0.01% | 1498 |
|
|
2024
Q2 | $10.1K | Sell |
1,738
-26,130
| -94% | -$152K | ﹤0.01% | 1463 |
|
|
2024
Q1 | $185K | Buy |
27,868
+272
| +1% | +$1.8K | ﹤0.01% | 2281 |
|
|
2023
Q4 | $116K | Buy |
27,596
+85
| +0.3% | +$359 | ﹤0.01% | 2435 |
|
|
2023
Q3 | $119K | Sell |
27,511
-7,474
| -21% | -$32.3K | ﹤0.01% | 2424 |
|
|
2023
Q2 | $231K | Sell |
34,985
-1,291
| -4% | -$8.53K | ﹤0.01% | 2286 |
|
|
2023
Q1 | $246K | Buy |
36,276
+8,684
| +31% | +$59K | ﹤0.01% | 2255 |
|
|
2022
Q4 | $204K | Buy |
27,592
+3,374
| +14% | +$24.9K | ﹤0.01% | 2289 |
|
|
2022
Q3 | $239K | Buy |
24,218
+7,111
| +42% | +$70.2K | ﹤0.01% | 2265 |
|
|
2022
Q2 | $187K | Buy |
+17,107
| New | +$187K | ﹤0.01% | 2167 |
|